SUMMARY Detection of rubella virus-specific IgM employing trypsin-treated human group 0 erythrocytes was evaluated using the method of sera fractionation on sucrose density gradients (SDG) and that of sera absorption with staphylococcal protein A. The former method proved to be highly specific and sensitive in confirming or excluding rubella by demonstration of specific IgM. (Calbiochem-Behring, Corp.). It is therefore likely that these erythrocytes wouild become more widely available in due course. In a comparative study (as yet unpublished) of all commercially-available rubella antibody testing kits marketed in the USA including virus haemagglutination-inhibition and enzyme-linked immunosorbentassays (ELISA), kits using trypsinised human 0 cells have been shown to be among the most specific methods in accurately detecting "true" rubella antibody-positive and -negative sera.2 However, the application of trypsinised human 0 erythrocytes for HAI testing after serum fractionation on sucrose density gradient or after absorption with protein A for the detection of rubella-specific IgM has yet to be evaluated. Our paper describes the detection of rubella-specific IgM by SDG and protein Accepted for publication 12 November 1980 A absorption using trypsin-treated human group 0 erythrocytes.
The use of trypsin-treated human group 0 erythrocytes instead of chick erythrocytes in the standard rubella haemagglutination-inhibition (HAI) test, has been shown to provide not only a more sensitive, less time consuming, and more economical test but also a procedure which is as specific as that employing chick erythrocytes.' Recently, trypsinised human 0 erythrocytes for rubella HAI testing have become available commercially (Calbiochem-Behring, Corp.) . It is therefore likely that these erythrocytes wouild become more widely available in due course. In a comparative study (as yet unpublished) of all commercially-available rubella antibody testing kits marketed in the USA including virus haemagglutination-inhibition and enzyme-linked immunosorbentassays (ELISA), kits using trypsinised human 0 cells have been shown to be among the most specific methods in accurately detecting "true" rubella antibody-positive and -negative sera. 2 However, the application of trypsinised human 0 erythrocytes for HAI testing after serum fractionation on sucrose density gradient or after absorption with protein A for the detection of rubella-specific IgM has yet to be evaluated. Our paper describes the detection of rubella-specific IgM by SDG and protein Accepted for publication 12 November 1980 A absorption using trypsin-treated human group 0 erythrocytes.
Material and methods

SERA
Sera were obtained from women who were exposed to or who had developed rubella-like illness and children with rashes who were referred for diagnosis to the Virus laboratory at the Department of Microbiology. Blood was collected (5-10 ml) and allowed to clot overnight at room temperature. Sera were separated by centrifugation at 900 g for five minutes and stored at -20°C until tested.
Sera were pre-treated with heparin/MnCl2 before centrifugation on SDG to remove the "heavy" nonspecific inhibitors of HAI which may sometimes be present in the IgM-containing fractions and which become detectable when the "long-incubation" procedure of HAI (when sera were incubated with antigens at 4°C overnight) is employed. To investigate whether rubella HAI antibody activity in the IgG fractions might "spill-over" and precede the IgG into the IgM fractions, sera that were devoid of rubella-specific IgM antibody (titre < 1/4) but had rubella IgG antibody ranging from 1/4 to 1/512 were fractionated on SDG and the position of the rubella HAI antibody activity in the various IgG fractions was observed. As shown in Table 1 , in 48 of 131 (36-64%)and 56 of 131 (42-75%) specimens, the rubella HAI antibody activity was visible in the first and second IgG fractions, respectively. Moreover, in 25 of 131 (19-08 %) specimens the rubella HAI antibody activity started in the third to the fifth IgG fraction. In contrast, in only 2 of 131 (1-53 %) specimens, "trace reactions" of rubella HAI activity were detected in one fraction ahead of the IgG fractions (Table 1) .
Our preliminary study' on the use of trypsin-treated human group 0 erythrocytes in the HAI test following SDG fractionation of sera has been extended to include tests on specificity. Thus, Table 2 shows that rubella-specific IgM could not be detected in any seropositive (HAI > 1/8) patients by SDG and negative by protein A/HAT. Since the four sera positive by protein A/HAI and negative by SDG were from patients without any evidence of a recent rubella infection and the four which were negative by protein A but positive by SDG, were obtained from patients with a recently documented postnatally acquired or congenitally acquired rubella, our investigation suggests that pre-absorption with protein A does not provide a reliable method for the diagnosis of rubella.
Discussion
The data presented in this paper clearly show that excellent separation of IgM from IgG and IgA can be achieved after fractionation on SDG with the system and conditions as reported. This is in contrast to the experience of Caul et al.6 7who appear to have failed to obtain good separation and therefore suggested 2-mercaptoethanol treatment of fractions to confirm the presence of specific IgM. Failure to achieve good separation of IgM from IgG or IgA may be due to several factors-for example, theuseof an inappropriate buffer to make the various sucrose concentrations, possible heat-inactivation of sera before fractionation on SDG, or the fact that the volumes of fractions collected may be too large.
We have shown that detection of rubella-specific IgM in fractionated sera with trypsin-treated human O erythrocytes is highly specific. Thus, HAI antibody activity was detected in the IgG and IgA fractions and not the IgM fractions of sera from patients with rubella antibodies of long duration. Furthermore, no rubella antibodies were detected in the IgM, IgG and IgA-containing fractions of seronegative persons, although rubella-specific IgM was detected in all of 16 (100 %) cases withevidence of postnatally-acquired or congenital rubella.
Absorption of sera with staphylocoocal protein A to remove IgG followed by HAI has been proposed as a simple method for the detection of rubellaspecific IgM in whole sera.5 Our data which compared the sensitivity and specificity of the protein A/HAI method to our standard and wellestablished SDG/HAI technique, show that there was a 71.43 % agreement between the two procedures. However, in 14'29 % of specimens the protein A/HAI method gave false-positive rubellaspecific IgM results and in another 14-29 % of the cases it gave false-negative rubella-specific IgM results. Some investigators have shown that absorption with protein A fails to remove IgG 3.8 Therefore, sera with an initally high rubella HAI antibody titre, may still retain titres of > 1/16 after treatment with protein A. In our study, all the sera that were rubella-specific IgM 13 and enzyme-linked-immunosorbent assays (ELISA)14 which have been applied in rubella-specific IgM diagnosis, seem to have a common limitation namely interference by rheumatoid factor'2-14 although a recently described RIA9 provided encouraging results. However, RIA systems cannot be applicable on large scale due to the complexity of the procedure including the preparation of highly-purified and highly-specific antihuman IgM 1251-label and because of the requirement for complex, expensive equipment such as a gamma-counter. In view of this, therefore, it appears that the SDG/HAI method should remain for the time being as the most applicable reference technique for the specific detection of rubella IgM.
